Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Sutro Biopharma, Inc.

Clinical trials sponsored by Sutro Biopharma, Inc., explained in plain language.

Sutro Biopharma, Inc. STRO NASDAQ

A biopharmaceutical company developing next-generation antibody-drug conjugates and immunotherapies.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Terminated 2

New drug STRO-004 takes on advanced cancers in early trial

Disease control Recruiting now

This early-phase study tests a new drug called STRO-004 in adults with advanced solid tumors that have not responded to standard treatments. The study has three parts: finding a safe dose of STRO-004 alone, testing that dose in more patients, and combining STRO-004 with another d…

Phase: PHASE1 • Sponsor: Sutro Biopharma, Inc. • Aim: Disease control

Last updated Aug 08, 2026 00:03 UTC